CK-MB is very valuable for the early diagnosis of AMI. The Biotime CK-MB test kit can perform the test accurately and rapidly within 15 minutes with Biotime Analyzers.
Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.
Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain, suspected Acute Coronary Syndrome(ACS) and Heart Failure(HF), etc.
IPv6 network supported 
